Successful stem cell therapy using umbilical cord blood-derived multipotent stem cells for Buerger's disease and ischemic limb disease animal model

Stem Cells

Volumn 24, Issue 6, 2006, Pages 1620-1626

  Kim, Sung Whan ^a   Han, Hoon ^b   Chae, Gue Tae ^a   Lee, Sung Hoon ^c   Bo, Sun ^c   Yoon, Jung Hee ^c   Lee, Yong Soon ^c   Lee, Kwang Soo ^d   Park, Hwon Kyum ^d   Kang, Kyung Sun ^c  

^a The Catholic University of Korea   (South Korea)

^b Histostem Co   (South Korea)

^c Seoul National University   (South Korea)

^d Hanyang University   (South Korea)

Author keywords

Buerger's disease; Cell transplantation; Cord blood; Mesenchymal stem cells

Indexed keywords

HLA ANTIGEN; PETHIDINE;

ADULT; ANGIOGRAPHY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY LIGATION; ARTERY WALL; ARTICLE; BUERGER DISEASE; BYPASS SURGERY; CASE REPORT; CONTROLLED STUDY; FEMORAL ARTERY; FOLLOW UP; HINDLIMB; HUMAN; HUMAN CELL; IN SITU HYBRIDIZATION; INTRACTABLE PAIN; LIMB ISCHEMIA; LUMBAR SYMPATHECTOMY; MALE; MOUSE; MULTIPOTENT STEM CELL; NONHUMAN; SKIN NECROSIS; STEM CELL TRANSPLANTATION; TREATMENT OUTCOME; UMBILICAL CORD BLOOD; VASCULAR RESISTANCE; ANIMAL; BAGG ALBINO MOUSE; CYTOLOGY; DISEASE MODEL; FETUS BLOOD; ISCHEMIA; MIDDLE AGED; NUDE MOUSE; PATHOLOGY; RADIOGRAPHY; TRANSPLANTATION; VASCULARIZATION; XENOGRAFT;

ANIMALIA; MUS MUSCULUS;

ADULT; ANGIOGRAPHY; ANIMALS; DISEASE MODELS, ANIMAL; FETAL BLOOD; HINDLIMB; HUMANS; ISCHEMIA; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; MIDDLE AGED; MULTIPOTENT STEM CELLS; STEM CELL TRANSPLANTATION; THROMBOANGIITIS OBLITERANS; TRANSPLANTATION, HETEROLOGOUS;

EID: 33747614767     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1634/stemcells.2005-0365     Document Type: Article

References (24)

1. Buerger L. Thromboangiitis obliterans: A study of vascular lesions leading to presenile spontaneous. Am J Med Sci 1908;136:567-580.
2. Mills JL, Porter JM. Buerger's disease: A review and update. Semin Vasc Surg 1993;6:14-23.
3. Matsushita M, Shionoya S, Matsumoto T. Urinary cotinine measurements in patients with Buerger's disease-effects of active and passive smoking on the disease process. J Vasc Surg 1991;14:53-58.
4. Grassi G, Serravalle G, Calhoun DA et al. Mechanisms responsible for sympathetic activation by cigarette smoking in human. Circulation 1994;90:248-253.
5. Ohta T, Ishioashi H, Hosaka M et al. Clinical and social consequences of Buerger disease. J Vasc Surg 2004;39:176-180.
6. Cooper LT, Tse TS, Mikhail MA et al. Long-term survival and amputation risk in thromboangiitis obliterans (Buerger's Disease). J Am Coll Cardiol 2004;44:2410-2411.
7. Fiessinger JN, Schafer M. Trial of iloprost versus aspirin treatment for critical limb ischemia of thromboangiitis obliterans: The TAO Study. Lancet 1990;335:555-557.
8. Matsushita M, Kuzuya A, Kobayashi M et al. Buerger's disease in a 19-year-old woman. J Vasc Surg 2003;38:175-179.
9. Saha K, Chabra N, Gulati SM. Treatment of patients with thromboangiitis obliterans with cyclophosphamide. Angiology 2001;52:399-407.
10. Inan M, Alat I, Kutlu R et al. Successful treatment of Buerger's Disease with intramedullary K-wire: The results of the first 11 extremities. Eur J Vasc Endovasc Surg 2005;29:277-280.
11. Kalka C, Masuda H, Takahashi T et al. Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc Natl Acad Sci U S A 2000;97:3422-3427.
12. Kang HJ, Kim HS, Zhang SY et al. Effect of intracoronary infusion of peripheral blood stem cells mobilized with granulocyte-colony stimulating factor on left ventricular systolic function and restenosis after coronary stenting in myocardial infarction: The MAGIC cell randomized clinical trial. Lancet 2004;363:751-756.
13. Rumpold H, Wolf D, Koeck R et al. Endothelial progenitor cells: A source for therapeutic vasculogenesis? J Cell Mol Med 2004;8:509-518.
14. Kawamoto A, Gwon H-C, Iwaguro H et al. Therapeutic potential of ex vivo expanded endothelial progenitor cells for myocardial ischemia. Circulation 2001;103:634-637.
15. Isner JM, Baumgartner I, Rauth G et al. Treatment of thromboangiitis obliterans (Buerger's disease) by intramuscular gene transfer of vascular endothelial growth factor: Preliminary clinical results. J Vasc Surg 1998;28:964-973.
16. Brodmann M, Renner W, Stark G et al. Vascular endothelial growth factor expression in patients suffering from thrombangitis obliterans. Int J Cardiol 2001;80:185-186.
17. Wang Y, Tagil K, Ripa RS et al. Effect of mobilization of bone marrow stem cells by granulocyte colony stimulating factor on clinical symptoms, left ventricular perfusion and function in patients with severe chronic ischemic heart disease. Int J Cardiol 2005;100:477-483.
18. Kang K-S, Kim SW, Oh YH et al. A thirty-seven-year-old spinal cord-injured female patient, transplanted of multipotent stem cells from human UC blood, with improved sensory perception and mobility, both functionally and morphologically; a case study. Cytotherapy 2005;7:368-373.
19. Kim J, Yu W, Kovalski K et al. Requirement for specific proteases in cancer cell intravasation as revealed by a novel semiquantitative PCR-based assay. Cell 1998;94:353-362.
20. Lothar J, Marco T, Jan T et al. Identification of human cells in brain xenografts and in neural co-cultures of rat by in situ hybridization with Alu probe. J Neurosci Methods 2003;126:69-77.
21. Salcedo R, Zhang X, Young HA et al. Angiogenic effects of prostaglandin E2 are mediated by up-regulation of CXCR4 on human microvascular endothelial cells. Blood 2003;102:1966-1977.
22. Kelkar BR. Induced angiogenesis for limb ischemia. Clin Orthop Relat Res 2003;412:234-240.
23. Fang TD, Salim A, Xia W et al. Angiogenesis is required for successful bone induction during distraction osteogenesis. J Bone Miner Res 2005;20:1114-1124.
24. Sasajima T, Kubo Y, Inabe M et al. Role of infrainguinal bypass in Buerger's disease: An eighteen-year experience. Eur J Vas Endovasc Surg 1997;13:186-192.